ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
63 089,09
6,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Reneo Pharmaceuticals Inc (RPHM)

  7. Reneo Pharmaceuticals Inc (RPHM) Actualités

RPHM Reneo Pharmaceuticals Inc

1,74
0,01 (0,58%)
Après les heures de négociation
Dernière mise à jour : 22:30:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Reneo Pharmaceuticals Inc RPHM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,58% 1,74 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,75 1,72 1,77 1,74 1,73
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/3/202412:35GLOBEReneo Pharmaceuticals Reports Fourth Quarter And Full Year..
25/3/202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
23/2/202422:00EDGAR2Form 8-K - Current report
05/2/202422:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/12/202315:26EDGAR2Form 8-K - Current report
14/12/202315:05GLOBEReneo Pharmaceuticals Announces Results from Pivotal STRIDE..
22/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202323:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:00EDGAR2Form 8-K - Current report
13/11/202313:35GLOBEReneo Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202312:50GLOBEReneo Pharmaceuticals to Participate in Upcoming Investor..
30/10/202321:47EDGAR2Form 8-K - Current report
25/10/202313:50GLOBEReneo Pharmaceuticals Announces Poster Presentation at..
09/10/202313:50GLOBEReneo Pharmaceuticals Announces Last Patient Last Visit in..
06/10/202314:30GLOBEReneo Pharmaceuticals to Participate in the Jefferies..
29/8/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202313:35GLOBEReneo Pharmaceuticals to Participate in Upcoming Investor..
28/8/202323:33EDGAR2Form 144 - Report of proposed sale of securities
10/8/202322:01EDGAR2Form 8-K - Current report
10/8/202313:35GLOBEReneo Pharmaceuticals Reports Second Quarter 2023 Financial..
30/6/202314:25GLOBEReneo Pharmaceuticals to Participate in SVB Securities..
26/6/202314:25GLOBEReneo Pharmaceuticals Added to Russell 2000® and Russell..
15/6/202318:44GLOBEReneo Pharmaceuticals Announces Presentation and Posters at..
31/5/202316:38GLOBEUpdate -- Reneo Pharmaceuticals to Participate at the..
31/5/202314:00GLOBEReneo Pharmaceuticals to Participate at the Jefferies..
11/5/202313:45GLOBEReneo Pharmaceuticals Reports First Quarter 2023 Financial..
04/5/202305:36GLOBEReneo Announces Pricing of Public Offering of Common Stock

Dernières Valeurs Consultées

NASDAQ
RPHM
Reneo Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés